TB-500
Anonymous community reports on TB-500 (thymosin beta-4) — injury recovery, systemic healing, and the Wolverine Stack. Real accounts on protocols and outcomes.
7 anonymous reports
related topics:
Community Q&A
- What does TB-500 do according to community accounts?
- TB-500 (synthetic thymosin beta-4) appears in community accounts as the systemic counterpart to BPC-157's more targeted healing action. The community framing: BPC-157 heals locally, TB-500 heals everywhere. Accounts describe TB-500 promoting new blood vessel formation, improving tissue repair across the body, and accelerating recovery from both acute injuries and chronic overuse damage. The most common context: combined with BPC-157 in the 'Wolverine Stack' for injury recovery. Standalone TB-500 accounts are less common — most users treat it as a stack component rather than a primary compound.
- How is TB-500 used for injury recovery in community protocols?
- Community protocols for injury recovery describe a loading and maintenance structure. Loading phase: 2mg twice per week for 4–6 weeks, typically subcutaneous injection away from the injury site (unlike BPC-157 where proximity to injury is described as beneficial). Maintenance phase: 2mg once per week or every two weeks depending on injury progress. Conditions appearing most frequently in TB-500 accounts: muscle tears, tendon damage, overuse injuries, post-surgical healing, and chronic joint inflammation. The accounts describing the fastest recovery consistently use TB-500 alongside BPC-157 rather than either alone.
- What is the difference between TB-500 and BPC-157?
- The most common question in TB-500 community accounts — and the answers are notably consistent. BPC-157 accounts describe more targeted, site-specific healing: gut lining, specific tendons, localized injuries. TB-500 accounts describe broader, systemic effects: full-body tissue repair, improved circulation, and recovery from systemic physical stress. The mechanisms cited in community discussion: BPC-157 for the healing signal at a specific location; TB-500 for creating the vascular and cellular environment that allows systemic healing. Community practice: use both. The Wolverine Stack (BPC-157 + TB-500) appears in more injury accounts than either compound alone, and comparative accounts favor the combination over either individually.
- What side effects does TB-500 cause?
- TB-500 has one of the cleanest side effect profiles in the community archive — frequently noted explicitly in accounts. Mild fatigue following a loading dose appears in some accounts, typically described as transient (24–48 hours). A small subset of accounts describes temporary increased hair shedding during the first few weeks, attributed to thymosin beta-4's role in hair follicle cycling — universally described as resolving without intervention. Injection site discomfort (standard for any subcutaneous injection) appears across accounts. No accounts describe serious or persistent adverse effects. The theoretical concern around angiogenic activity (same as BPC-157) appears in community discussion but is not represented in account-based adverse event reports.
- Does TB-500 affect hair growth — what do community accounts say?
- TB-500 and hair appear in community accounts in two distinct contexts: shedding during use and potential regrowth effects. The shedding context: a subset of accounts describe temporary increased hair shedding in the first 2–4 weeks of a TB-500 protocol, attributed to thymosin beta-4's role in shifting hair follicles from resting (telogen) to growing (anagen) phase. This is described as self-resolving and generally interpreted as a sign of follicle cycling rather than damage. The regrowth context: accounts from users who noticed improved hair thickness or density after TB-500 cycles are present but represent a smaller fraction of the archive — not enough to describe it as a primary hair growth compound. The community framing: TB-500 is not a hair peptide, but its systemic tissue effects include follicle cycling that some users experience as improved hair quality as a secondary outcome.
- What is the difference between TB4 and TB-500?
- TB4 (thymosin beta-4) is the full naturally occurring peptide. TB-500 is a synthetic analogue of the most active fragment of thymosin beta-4 — specifically the actin-binding domain responsible for most of TB4's healing and regenerative activity. Community accounts treat them as functionally equivalent in practice, with TB-500 appearing far more frequently because it is more stable, more widely available, and less expensive to synthesise than full-length TB4. Accounts that specifically distinguish between them describe TB-500 as producing the same tissue repair and anti-inflammatory effects at lower cost. The occasional account describing 'natural TB4' is almost always referring to a sourcing preference rather than a meaningfully different compound. For community purposes: TB-500 is the usable, stable form of the TB4 mechanism.